Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 15143 publications
Vaginitis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 Summary GlobalData's clinical trial report, “Vaginitis Global Clinical Trials Review, H2, 2014' provides data on the Vaginitis clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Dec, 2014 68 pages
Trichuriasis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 Summary GlobalData's clinical trial report, “Trichuriasis Global Clinical Trials Review, H2, 2014' provides data on the Trichuriasis clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Dec, 2014 56 pages
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Respiratory Syncytial Virus (RSV) Infections clinical trial scenario. This report provides elemental information and ... and top five national contributions in each Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor ...

Nov, 2014 105 pages
Pyelonephritis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 Summary GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2014' provides data on the Pyelonephritis clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Dec, 2014 88 pages
Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Onychomycosis (Tinea Unguium) clinical trial scenario. This report provides elemental information and data relating ... and top five national contributions in each Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor ...

Nov, 2014 87 pages
Malignant Pleural Effusion Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Review, H2, 2014' provides data on the Malignant Pleural Effusion clinical trial scenario. This report provides elemental information and data relating ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 71 pages
Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2014' provides data on the Lymphangioleiomyomatosis clinical trial scenario. This report provides elemental information and data ...

Nov, 2014 73 pages
Lyme Disease Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Lyme Disease. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Nov, 2014 59 pages
Kaposi's Sarcoma Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Kaposi’s Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2014 79 pages
Cystic Fibrosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... and data relating to the clinical trials on Cystic Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Nov, 2014 108 pages
Bronchiolitis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 Summary GlobalData's clinical trial report, “Bronchiolitis Global Clinical Trials Review, H2, 2014' provides data on the Bronchiolitis clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Nov, 2014 71 pages
Brazil Pharmaceutical Market Outlook 2018 US$ 1,000.00

... ’s overall healthcare services and facilities. In our latest research study “Brazil Pharmaceutical Market Outlook 2018”, RNCOS’ analysts have identified the ... , which stood at US$ 26.89 Billion in 2013, is expected to grow at a CAGR of 14.5% during 2013-2018. RNCOS’ analysis shows that the Over-the-Counter drug ...

Dec, 2014 90 pages
Asia Pacific Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin US$ 1,500.00

The industry research publication titled ‘Asia Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin’ presents a comprehensive analysis of ... . The world’s largest diabetic population resides in Asia Pacific due to which the demand for insulin is on a constant rise. Japan, China and ...

Sep, 2014 146 pages
Rodos BioTarget GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Rodos BioTarget GmbH’s pipeline products Reasons ... of focus Identify new drug targets and therapeutic classes in the Rodos BioTarget GmbH’s R&D portfolio and develop key strategic initiatives to reinforce ...

Dec, 2014 18 pages
RAPID Pharmaceuticals AG - Product Pipeline Review - 2014 US$ 1,500.00

... The report reviews current pipeline of RAPID Pharmaceuticals AG’s human therapeutic division and enlists all their major and minor projects The report ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the RAPID Pharmaceuticals AG’s pipeline products ...

Dec, 2014 22 pages
Piramal Enterprises Limited - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Piramal Enterprises Limited’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Piramal Enterprises Limited’s pipeline products Reasons ...

Dec, 2014 44 pages
Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Panmira Pharmaceuticals, LLC.’s pipeline products Reasons to ...

Dec, 2014 22 pages
OncoSec Medical Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the OncoSec Medical Inc.’s pipeline products Reasons ... of focus Identify new drug targets and therapeutic classes in the OncoSec Medical Inc.’s R&D portfolio and develop key strategic initiatives to reinforce ...

Dec, 2014 29 pages
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014 US$ 2,000.00

... III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014’, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome), ...

Dec, 2014 59 pages
Kite Pharma, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Kite Pharma, Inc.’s pipeline products Reasons ...

Dec, 2014 31 pages
Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Grupo Ferrer Internacional, S.A.’s pipeline products Reasons ...

Dec, 2014 38 pages
Creabilis SA - Product Pipeline Review - 2014 US$ 1,500.00

Creabilis SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Creabilis SA - Product Pipeline Review - 2014’, provides an overview of the Creabilis SA’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental ...

Dec, 2014 26 pages
Bukwang Pharm.Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Bukwang Pharm.Co., Ltd.’s human therapeutic ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Bukwang Pharm.Co., Ltd.’s pipeline products Reasons ...

Dec, 2014 29 pages
Blueprint Medicines - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Blueprint Medicines’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Blueprint Medicines’s pipeline products ...

Dec, 2014 21 pages
Biosidus S.A. - Product Pipeline Review - 2014 US$ 1,500.00

Biosidus S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Biosidus S.A. - Product Pipeline Review - 2014’, provides an overview of the Biosidus S.A.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic ...

Dec, 2014 23 pages
biOasis Technologies Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of biOasis Technologies Inc.’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the biOasis Technologies Inc.’s pipeline products Reasons to ...

Dec, 2014 26 pages
BioApex, s.r.o. - Product Pipeline Review - 2014 US$ 1,500.00

BioApex, s.r.o. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘BioApex, s.r.o. - Product Pipeline Review - 2014’, provides an overview of the BioApex, s.r.o.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic ...

Dec, 2014 19 pages
ASKA Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the ASKA Pharmaceutical Co., Ltd.’s pipeline products Reasons to ...

Dec, 2014 30 pages
Osteoporosis Drugs Market in the APAC Region 2015-2019 US$ 2,500.00

... associated with this disease. TechNavio's analysts forecast the Osteoporosis Drugs market in APAC to grow at a CAGR of 4.73 percent over the period 2014- ... The report also includes a discussion of the key vendors operating in this market. Key Vendors Amgen Eli Lilly Merck Novartis Other Prominent ...

Dec, 2014 73 pages
Global Pharmaceuticals Wholesale and Distribution Market 2015-2019 US$ 2,500.00

... and cost effective. TechNavio's analysts forecast the Global Pharmaceuticals Wholesale and Distribution market to grow at a CAGR of 6.82 percent over the period ... detailed list, view our report Market Trend Adoption of New Modes of Pharmaceuticals Delivery For a full, detailed list, view our report Key ...

Dec, 2014 85 pages
Global Multiple Myeloma Drugs Market 2015-2019 US$ 3,000.00

... myeloma in the suspected patients. TechNavio's analysts forecast the Global Multiple Myeloma Drugs market to grow at a CAGR of 8.50 percent over the period 2014- ... Sankyo Genta Merck Sharp and Dohme Oncotherapeutics PharmaMar Teva Market Driver Presence of Unmet Needs For a full, detailed list, view ...

Dec, 2014 115 pages
Opioids Market Overview to 2023 - Opioids in Emerging Markets US$ 2,995.00

... due to recent changes to their palliative care policies. Although the opioids market in emerging countries is small, it is expected to grow at a faster pace in forecast ... on the unmet need in the opioids market Understand the market size and growth potential in emerging markets and identify high-potential ...

Nov, 2014 72 pages
United States Anesthesia Drugs Market & Forecast US$ 1,450.00

... Anesthetic Drugs Market has been further divided into 1. Propofol 2. Benzodiazepines Class (Diazepam and Midazolam) 3. Fospropofol Disodium 4. Ketamine 5. Methohexital Sodium 6. Pentobarbital 7. Etomidate 8. Fentanyl United States Local Anesthetic Market has been further divided into 1. Articane ...

Dec, 2014 74 pages
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update US$ 10,995.00

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Simponi and Entyvio, which will favor the increased uptake of biologics ...

Sep, 2014 341 pages
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics andRevenue Forecasts to 2021, NAIC... US$ 1,995.00

... , benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vitamins, Botanicals, Nutritional Supplements and ...

Dec, 2014 68 pages
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414 US$ 1,995.00

... metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. KEY FINDINGS: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $39.5 billion by 2021. Vaccines, Skin Replacement Products and Biologicals Manufacturing ...

Dec, 2014 65 pages
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 US$ 1,995.00

... , benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. KEY FINDINGS: Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.) to reach $315.6 billion by 2021. Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry, ...

Dec, 2014 79 pages
Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325412 US$ 1,995.00

... data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals and Drug Manufacturing Industry (U.S.) to reach $227.6 billion by 2021. Pharmaceuticals and Drug Manufacturing Industry, including Average EBITDA, ...

Dec, 2014 74 pages
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 424200 US$ 1,995.00

... metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $1 trillion by 2021. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors ...

Dec, 2014 57 pages
Global Anti-Obesity Drugs Market 2015-2019 US$ 2,500.00

... of obesity that are available in the market. TechNavio's report, the Global Anti-obesity Drugs Market 2015-2019, has been prepared based on an ... . The report also includes a discussion of the key vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors Arena Pharmaceuticals F. ...

Nov, 2014 72 pages
Xiber Science GmbH - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Xiber Science GmbH’s pipeline products Reasons ...

Nov, 2014 20 pages
Sorrento Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Sorrento Therapeutics, Inc.’s pipeline products Reasons ...

Nov, 2014 67 pages
Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Hisamitsu Pharmaceutical Co., Inc.’s pipeline products Reasons ...

Nov, 2014 28 pages
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark US$ 1,995.00

... Landscape - Denmark SUMMARY GlobalData, the industry analysis specialist, has released its latest report, 'CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark'. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement ...

Dec, 2014 253 pages
Vitamin China E-News 1411 US$ 8,910.00

... many enterprises launched new products since this month, like CSPC launching vitamin drink and Haineng Bioengineering formally launching 25-Hydroxyvitamin D3, which may bring new opportunities for vitamin industry. To be noticed, the RMB/USD exchange rate in this issue is 6.1525 (the People's Bank of China ...

Dec, 2014 31 pages
China Pharmaceutical Raw Materials Mfg. Industry Data Report US$ 580.00

... raw materials mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of pharmaceutical raw materials mfg. sector, provides an important reference for investors' selection of target regions to make investment based on Zeefer ...

Dec, 2014 22 pages
China Pharmaceutical & Medicine Mfg. Industry Data Report US$ 580.00

... & medicine mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of pharmaceutical & medicine mfg. sector, provides an important reference for investors' selection of target regions to make investment based on Zeefer Industry ...

Dec, 2014 22 pages
China Biopharmaceuticals Mfg. Industry Data Report US$ 580.00

This data report provides key statistics and concise analysis on biopharmaceuticals mfg. industry in China. It presents an overview on biopharmaceuticals mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of biopharmaceuticals ...

Dec, 2014 22 pages
Fast Growing China Pharmaceutical Market US$ 1,000.00

... robust growth in the coming years. The growth is boosted by the growing aging population, increasing wealth and government reforms. It is expected that ... to approximately USD 1 trillion in 2020. Why should the report be purchased? The report 'Fast Growing China Pharmaceutical Market” highlights key dynamics ...

Dec, 2014 30 pages
Verastem, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Verastem, Inc.’s pipeline products ... drug targets and therapeutic classes in the Verastem, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 32 pages
1 2 3 4 5 >
Skip to top